Search Results - "DAUPLAT, J"

Quality of life after mastectomy with or without immediate breast reconstruction by Dauplat, J., Kwiatkowski, F., Rouanet, P., Delay, E., Clough, K., Verhaeghe, J. L., Raoust, I., Houvenaeghel, G., Lemasurier, P., Thivat, E., Pomel, C., Abrial, C., Afonso, J., Bannier, M., Body, G., Baron, M., Bergzoll, C., Chauvet, M. P., Classe, J. M., Cothier‐Savey, I., Dejode, M., Dessogne, P., Doridot, V., Durando, X., Faucher, A., Faure, C., Figl, A., Fitoussi, A., Flipo, B., Fondrinier, E., Garbay, J. R., Giacalone, P. L., Gimbergue, P., Guillemin, F., Gutowski, M., Houpeau, J. L., Inguenault, C., Lambaudie, E., Lantieri, L., Le Bouedec, G., Lepage, C., Loustalot, C., Machiavello, J. C., Monrigal, E., Mourregot, A., Nos, C., Paradol, P. O., Rimareix, F., Rodier, J. F., Rouzier, R., Saint‐Aubert, B., Salmon, R. J., Scherer, C., Toussoun, G., Tunon de Lara, C., Uzan, S., Weitbruch, D.

“…Background Mastectomy with immediate breast reconstruction (IBR) is a surgical strategy in breast cancer when breast‐conserving surgery is not an option. There…”
Get full text

Survival effect of laparoscopic para‐aortic staging in locally advanced cervical cancer: a retrospective cohort analysis by Pomel, C, Martinez, A, Bourgin, C, Beguinot, M, Benoit, C, Naik, R, Dauplat, J, Lebouedec, G, Ferron, G

“…Objective This study compares two methods of evaluating para‐aortic node involvement in locally advanced cervical cancer (LACC) in order to define external…”
Get full text

Tu-be or not tu-be: That is the question… About serous ovarian carcinogenesis by Chene, G, Dauplat, J, Radosevic-Robin, N, Cayre, A, Penault-Llorca, F

“…Abstract Our understanding of the early natural history of epithelial ovarian carcinoma is limited by the access to early lesions as the disease is very often…”
Get full text

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer by CHOLLET, P, AMAT, S, CURE, H, DE LATOUR, M, LE BOUEDEC, G, MOURET-REYNIER, M-A, FERRIERE, J-P, ACHARD, J-L, DAUPLAT, J, PENAULT-LLORCA, F

“…Only a few papers have been published concerning the incidence and outcome of patients with a pathological complete response after cytotoxic treatment in…”
Get full text

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study by Monrigal, E, Dauplat, J, Gimbergues, P, Le Bouedec, G, Peyronie, M, Achard, J.L, Chollet, P, Mouret-Reynier, M.A, Nabholtz, J.M, Pomel, C

“…Abstract Purpose To evaluate the feasability of immediate breast reconstruction (IBR) following mastectomy after neoadjuvant chemotherapy (NACT) and radiation…”
Get full text

Systematic (complete) para-aortic lymphadenectomy: description of a novel surgical classification with technical and anatomical considerations by Pomel, C, Naik, R, Martinez, A, Ferron, G, Nassif, J, Dauplat, J, Jeyarajah, A

“…Please cite this paper as: Pomel C, Naik R, Martinez A, Ferron G, Nassif J, Dauplat J, Jeyarajah A. Systematic (complete) para‐aortic lymphadenectomy:…”
Get full text

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at Presentation by Gimbergues, P., Abrial, C., Durando, X., Bouedec, G. Le, Cachin, F., Penault-Llorca, F., Mouret-Reynier, M. A., Kwiatkowski, F., Maublant, J., Tchirkov, A., Dauplat, J.

“…Background In breast cancer, neoadjuvant chemotherapy (NAC) is widely used in order to enable a conservative surgery. In patients treated with NAC, the use of…”
Get full text

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate by AMAT, S, BOUGNOUX, P, PENAULT-LLORCA, F, FETISSOF, F, CURE, H, KWIATKOWSKI, F, ACHARD, J-L, BODY, G, DAUPLAT, J, CHOLLET, P

“…Docetaxel (Taxotere), alone or in combination with other anticancer agents, has proven efficacy in the first- and second-line treatment of metastatic breast…”
Get full text

Laparoscopic restaging of borderline ovarian tumours (BLOT): a retrospective study of 142 cases by Azuar, A.S, Bourdel, N, Ferrarrese, G, Dauplat, J, Mage, G, Canis, M

“…Abstract Objectives Primary objective: To analyse the impact of restaging, on recurrences and survival, in BLOT. Secondary objective: To cluster patients who…”
Get full text

Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients by Sorin, T, Fyad, J.P, Delay, E, Rouanet, P, Rimareix, F, Houpeau, J.L, Classe, J.M, Garrido, I, Tunon De Lara, C, Dauplat, J, Bendavid, C, Houvenaeghel, G, Clough, K.B, Sarfati, I, Leymarie, N, Trudel, M, Salleron, J, Guillemin, F, Oldrini, G, Brix, M, Dolivet, G, Simon, E, Verhaeghe, J.L, Marchal, F

“…Abstract Women who have undergone surgical treatment for breast cancer often benefit from a contralateral reduction mammaplasty (CRM) aimed at symmetrization…”
Get full text

Ovarian epithelial dysplasia after ovulation induction: time and dose effects by Chene, G., Penault-Llorca, F., Le Bouëdec, G., Mishellany, F., Dauplat, M.M., Jaffeux, P., Aublet-Cuvelier, B., Pouly, J.L., Dechelotte, P., Dauplat, J.

“…BACKGROUND Ovarian epithelial dysplasia was first described after prophylactic oophorectomies for genetic risk. Ovarian stimulation has been considered as a…”
Get full text

Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen by Chene, G, Radosevic-Robin, N, Tardieu, A S, Cayre, A, Raoelfils, I, Dechelotte, P, Dauplat, J, Penault Llorca, F

“…Ovarian epithelial dysplasia was initially described in material from prophylactic oophorectomies for BReast CAncer gene (BRCA) mutation. Similar…”
Get full text

Neoadjuvant chemotherapy for unresectable ovarian carcinoma: A French multicenter study by ANSQUER, Yan, LEBLANC, Eric, FOURME, Emmanuelle, CASTAIGNE, Damiene, QUERLEU, Denis, DARGENT, Daniel, CLOUGH, Krichna, MORICE, Philippe, DAUPLAT, Jacques, MATHEVET, Patrice, LHOMME, Catherine, SCHERER, Christophe, TIGAUD, Jean-Dominique, BENCHAIB, Mehdi

“…Initial debulking surgery followed by chemotherapy is the current treatment for International Federation of Gynecology and Obstetrics Stage IIIC/IV ovarian…”
Get full text

Intraoperative Imprint Cytology Examination of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients by Gimbergues, P., Dauplat, M. M., Durando, X., Abrial, C., Le Bouedec, G., Mouret-Reynier, M. A., Cachin, F., Kwiatkowski, F., Tchirkov, Andrei, Dauplat, J., Penault-Llorca, F.

“…Background Intraoperative imprint cytology (IC) is one of several accurate, proven methods to detect tumor cells in sentinel lymph nodes (SLN) from patients…”
Get full text

Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer by Dauplat, J, Chene, G, Pomel, C, Dauplat, M.M, Bouëdec, G.Le, Mishellany, F, Lagarde, N, Bignon, Y.J, Jaffeux, P, Aublet-Cuvelier, B, Dechelotte, P, Pouly, J.L, Penault-Llorca, F

“…Abstract Aim Ovarian epithelial dysplasia (OED) was first described after prophylactic oophorectomy for genetic risk of ovarian cancer. In light of Fathalla’s…”
Get full text

Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy by Amat, Sophie, Penault-Llorca, Frederique, Cure, Hervew, Le Bouedëc, Guillaume, Achard, Jean-Louis, Van Praagh, Isabelle, Feillel, Viviane, Mouret-Reynier, Marie-Ange, Dauplat, Jacques, Chollet, Philippe

“…The Scarff-Bloom-Richardson (SBR) grade, an important prognostic factor in breast cancer, was also associated with cell proliferation, a consistent indicator…”
Get more information

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients by BAY, J-O, FLEURY, J, CHOUFI, B, TOURNILHAC, O, VINCENT, C, BAILLY, C, DAUPLAT, J, VIENS, P, FAUCHER, C, BLAISE, D

“…Allogeneic hematopoietic stem cell transplantation is often used to treat hematologic malignancies. The efficacy of this procedure is due to both myeloablative…”
Get full text

Clinicopathological Factors and Nomograms Predicting Nonsentinel Lymph Node Metastases After Neoadjuvant Chemotherapy in Breast Cancer Patients by Gimbergues, P., Abrial, C., Durando, X., Le Bouedec, G., Cachin, F., Penault-Llorca, F., Mouret-Reynier, M. A., Kwiatkowski, F., Maublant, J., Tchirkov, A., Dauplat, J.

“…Background Studies have demonstrated the feasibility and accuracy of sentinel lymph node (SLN) biopsy after neoadjuvant chemotherapy (NAC) in breast cancer…”
Get full text

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results by Legros, M, Dauplat, J, Fleury, J, Cure, H, Suzanne, F, Chassagne, J, Bay, J O, Sol, C, Canis, M, Condat, P, Choufi, B, Tavernier, F, Glenat, C, Chollet, P, Plagne, R

“…A series of 53 patients with poor-prognosis epithelial ovarian cancer treated with high-dose chemotherapy (HDC) followed by hematopoietic rescue was…”
Get more information

Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee by Eisinger, F., Alby, N., Bremond, A., Dauplat, J., Espié, M., Janiaud, P., Kuttenn, F., Lebrun, J.-P., Lefranc, J.-P., Pierret, J., Sobol, H., Stoppa-Lyonnet, D., Thouvenin, D., Tristant, H., Feingold, J.

“…Background and purpose: Almost 10% of breast and ovarian cancers are familial, and the majority are linked to BRCA1 and BRCA2 germline mutations. Despite…”
Get full text